Litcius/Paper detail

Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis

Giuseppe Fallara, Federico Belladelli, Daniele Robesti, Daniele Raggi, Luigi Nocera, Laura Marandino, Matthew D. Galsky, Francesco Montorsi, Bernard Malavaud, Guillaume Ploussard, Andrea Necchi, Alberto Martini

2022Critical Reviews in Oncology/Hematology13 citationsDOI

Topics & Concepts

Prostate cancerEnzalutamideMedicineAndrogenAndrogen deprivation therapyOncologyAntiandrogenInternal medicineAbiraterone acetateAndrogen suppressionUrologyAndrogen receptorCancerHormoneProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBone health and treatments
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis | Litcius